Biotest vz. Aktie
27,50EUR | 0,10EUR | 0,36% |
WKN: 522723 / ISIN: DE0005227235
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 1 837 | 1 928 | 1 967 | 2 228 | 2 426 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,25 | 0,26 | 0,23 | 0,28 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 523 | 556 | 522 | 619 | 757 |
Summe Anlagevermögen | 612 | 604 | 609 | 612 | 688 |
Summe Aktiva | 1 134 | 1 161 | 1 131 | 1 232 | 1 444 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 410 | 469 | 530 | 644 | 690 |
Summe Fremdkapital | 657 | 719 | 751 | 861 | 945 |
Summe Eigenkapital | 477 | 442 | 380 | 371 | 499 |
Summe Passiva | 1 134 | 1 161 | 1 131 | 1 232 | 1 444 |
Adresse
Landsteinerstrasse 5, 63303 Dreieich | |
Telefon | +49 (6103) 801-0 |
Fax | +49 (6103) 801-150 |
Internet | http://www.biotest.de |
Management
Bernhard R. M. Ehmer
Chairman-Supervisory Board |
Christian Polus
Head-Information Technology |
Christina Erb
Head-Human Resources |
David Ian Bell
Member-Supervisory Board |
Dirk Schuck
Member-Supervisory Board |
Enrico D'Aiuto
Head-Marketing & Sales |
Josefine Buth
Head-Regulatory Affairs |
Jürgen Heilmann
Member-Supervisory Board |
Martin Mller
Chief Financial Officer |
Martin Möller
Head-Group Finance & Treasury |
Monika Buttkereit
Head-Investor Relations |
Oliver Hein
Head-Risk & Compliance |
Peter Janssen
Chairman-Management Board |
Raimon Grifols Roura
Member-Supervisory Board |
Stephan Fleck
Head-Controlling |
Tomás Dagá Gelabert
Vice Chairman-Supervisory Board |
Uta Kemmerich-Keil
Member-Supervisory Board |